# Kulicke & Soffa Industries Inc: overview

KLIC · Nasdaq · CIK 56978 · [Technology](/sectors/technology.md) · fiscal year ends Oct 3

Pages: [Overview](/companies/klic.md) · [Financials](/companies/klic/financials.md) · [Filings](/companies/klic/filings.md) · [Insiders](/companies/klic/insiders.md)

Latest reported revenue: [$330.4m](/filings/0000056978-26-000032.md) for Q3 FY2026, three months to 2026-07-04, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0000056978-26-000032).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-09-28) | Q1 FY2025 (2024-12-28) | Q2 FY2025 (2025-03-29) | Q3 FY2025 (2025-06-28) | Q4 FY2025 (2025-10-04) | Q1 FY2026 (2026-01-03) | Q2 FY2026 (2026-04-04) | Q3 FY2026 (2026-07-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [181 d](/filings/0000056978-25-000081.md) | [166](/filings/0000056978-26-000012.md) | [162](/filings/0000056978-26-000020.md) | [148](/filings/0000056978-26-000032.md) | [178 d](/filings/0000056978-25-000081.md) | [200](/filings/0000056978-26-000012.md) | [243](/filings/0000056978-26-000020.md) | [330](/filings/0000056978-26-000032.md) |
| Gross margin | % | [48.3% d](/filings/0000056978-25-000081.md) | [52.4%](/filings/0000056978-26-000012.md) | [24.9%](/filings/0000056978-26-000020.md) | [46.7%](/filings/0000056978-26-000032.md) | [45.7% d](/filings/0000056978-25-000081.md) | [49.6%](/filings/0000056978-26-000012.md) | [49.3%](/filings/0000056978-26-000020.md) | [47.8%](/filings/0000056978-26-000032.md) |
| Operating margin | % | [1.5% d](/filings/0000056978-25-000081.md) | [52.2%](/filings/0000056978-26-000012.md) | [(52.3%)](/filings/0000056978-26-000020.md) | [(4.1%)](/filings/0000056978-26-000032.md) | [0.5% d](/filings/0000056978-25-000081.md) | [8.9%](/filings/0000056978-26-000012.md) | [15.9%](/filings/0000056978-26-000020.md) | [20.7%](/filings/0000056978-26-000032.md) |
| Net margin | % | [6.7% d](/filings/0000056978-25-000081.md) | [49.1%](/filings/0000056978-26-000032.md) | [(52.2%)](/filings/0000056978-26-000032.md) | [(2.2%)](/filings/0000056978-26-000032.md) | [3.6% d](/filings/0000056978-25-000081.md) | [8.4%](/filings/0000056978-26-000032.md) | [14.5%](/filings/0000056978-26-000032.md) | [17.4%](/filings/0000056978-26-000032.md) |
| Diluted EPS | $ per share | not reported | [1.51](/filings/0000056978-26-000012.md) | [(1.59)](/filings/0000056978-26-000020.md) | [(0.06)](/filings/0000056978-26-000032.md) | not reported | [0.32](/filings/0000056978-26-000012.md) | [0.66](/filings/0000056978-26-000020.md) | [1.07](/filings/0000056978-26-000032.md) |
| Free cash flow | $m | [29.2 d](/filings/0000056978-25-000081.md) | [8.7](/filings/0000056978-26-000012.md) | [77.9 d](/filings/0000056978-26-000020.md) | [4.1 d](/filings/0000056978-26-000032.md) | [5.6 d](/filings/0000056978-25-000081.md) | [(11.6)](/filings/0000056978-26-000012.md) | [6.2 d](/filings/0000056978-26-000020.md) | [40.9 d](/filings/0000056978-26-000032.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-10-02) | FY2022 (2022-10-01) | FY2023 (2023-09-30) | FY2024 (2024-09-28) | FY2025 (2025-10-04) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,518](/filings/0000056978-23-000172.md) | [1,504](/filings/0000056978-24-000148.md) | [742](/filings/0000056978-25-000081.md) | [706](/filings/0000056978-25-000081.md) | [654](/filings/0000056978-25-000081.md) |
| Gross margin | % | [45.9%](/filings/0000056978-23-000172.md) | [49.8%](/filings/0000056978-24-000148.md) | [48.3%](/filings/0000056978-25-000081.md) | [38.1%](/filings/0000056978-25-000081.md) | [42.5%](/filings/0000056978-25-000081.md) |
| Operating margin | % | [27.2%](/filings/0000056978-23-000172.md) | [31.3%](/filings/0000056978-24-000148.md) | [5.3%](/filings/0000056978-25-000081.md) | [(13.1%)](/filings/0000056978-25-000081.md) | [(0.5%)](/filings/0000056978-25-000081.md) |
| Net margin | % | [24.2%](/filings/0000056978-23-000172.md) | [28.8%](/filings/0000056978-24-000148.md) | [7.7%](/filings/0000056978-25-000081.md) | [(9.8%)](/filings/0000056978-25-000081.md) | [0.0%](/filings/0000056978-25-000081.md) |
| Diluted EPS | $ per share | [5.78](/filings/0000056978-23-000172.md) | [7.09](/filings/0000056978-24-000148.md) | [0.99](/filings/0000056978-25-000081.md) | [(1.24)](/filings/0000056978-25-000081.md) | [0.00](/filings/0000056978-25-000081.md) |
| Free cash flow | $m | [277](/filings/0000056978-23-000172.md) | [367](/filings/0000056978-24-000148.md) | [129](/filings/0000056978-25-000081.md) | [14.9](/filings/0000056978-25-000081.md) | [96.4](/filings/0000056978-25-000081.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/klic/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.20bn | 9,007,442 |  | Added +299,541 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $355.2m | 2,655,650 |  | Added +168,394 |
| [JPMORGAN CHASE & CO](/funds/19617.md) | 2026-06-30 | $345.5m | 2,673,813 |  | Added +2,362,442 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $277.3m | 2,069,773 |  | Added +50,247 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $202.5m | 1,513,938 |  | Added +221,237 |
| [Point72 Asset Management, L.P.](/funds/1603466.md) | 2026-06-30 | $179.6m | 1,342,415 |  | Reduced −627,049 |
| [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $153.0m | 1,144,210 |  | Reduced −414,945 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $145.5m | 1,088,175 |  | Reduced −153,082 |
| [Copeland Capital Management, LLC](/funds/1541743.md) | 2026-06-30 | $133.8m | 1,000,293 |  | Reduced −150,727 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $129.2m | 966,277 |  | Added +15,793 |

## Recent filings

[All 1,682 filings](/companies/klic/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 13:14 ET | [8-K](/filings/0000056978-26-000036.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000056978-26-000036 |
| 2026-08-17 | 21:01 ET | [8-K](/filings/0000056978-26-000034.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000056978-26-000034 |
| 2026-08-06 | 12:51 ET | [10-Q](/filings/0000056978-26-000032.md) | Quarterly report, period 2026-07-04 | 0000056978-26-000032 |
| 2026-08-05 | 20:07 ET | [8-K](/filings/0000056978-26-000030.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000056978-26-000030 |
| 2026-05-07 | 12:32 ET | [10-Q](/filings/0000056978-26-000020.md) | Quarterly report, period 2026-04-04 | 0000056978-26-000020 |
| 2026-05-06 | 20:06 ET | [8-K](/filings/0000056978-26-000018.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000056978-26-000018 |
| 2026-03-05 | 13:54 ET | [8-K](/filings/0000056978-26-000014.md) | 5.07 Shareholder vote results | 0000056978-26-000014 |
| 2026-02-05 | 13:40 ET | [10-Q](/filings/0000056978-26-000012.md) | Quarterly report, period 2026-01-03 | 0000056978-26-000012 |
| 2026-02-04 | 21:06 ET | [8-K](/filings/0000056978-26-000010.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000056978-26-000010 |
| 2026-01-22 | 13:15 ET | [DEF 14A](/filings/0000056978-26-000006.md) | Proxy statement, period 2025-10-04 | 0000056978-26-000006 |

## Latest annual report

[Form 10-K for the fiscal year ended Oct 4, 2025](/filings/0000056978-25-000081.md), filed Nov 20, 2025.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 56978
- Tickers: KLIC
- Exchange: Nasdaq
- SIC code: 3674 Semiconductors & Related Devices
- State of incorporation: PA
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.